GlassScriptPhysician profile
Michael W Sicard
NPI 1508834847
$17,015.07
in general payments reported to CMS, 2019-2025
21 companies · $1,971 in 2025
The $1,971 reported for 2025 was more than what 89% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,613 · 2020: $101 · 2021: $655 · 2022: $1,003 · 2023: $2,830 · 2024: $8,842 · 2025: $1,971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,787 · Consulting Fee: $4,500 · Food and Beverage: $4,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,787.20 |
| Consulting Fee | $4,500.00 |
| Food and Beverage | $4,355.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurent Medical Limited | $9,104.72 | 2022-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Medtronic, INC. | $2,048.53 | 2023-2025 | Sinuva, Propel, Stealthstation S8 Platform |
| Optinose US, INC. | $956.87 | 2019-2025 | |
| Genzyme Corporation | $951.84 | 2019-2025 | |
| Acclarent, INC | $854.03 | 2019-2023 | Trudi Nav Cable, Acclarent Navwire, Acclarent Aera |
| Regeneron Healthcare Solutions, INC. | $446.55 | 2022-2024 | Dupixent |
| Aerin Medical INC. | $443.19 | 2019-2025 | |
| Integra Lifesciences Corporation | $416.53 | 2024-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Stryker Corporation | $376.69 | 2019-2025 | Xpress Ent Dilation System, Scopis Ent |
| Medtronic USA, INC. | $363.79 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $262.83 | 2019-2025 | Tezspire |
| Intersect Ent, INC. | $219.26 | 2019-2021 | |
| Glaxosmithkline, LLC. | $142.99 | 2025 | Nucala |
| Inspire Medical Systems, INC. | $120.33 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $115.74 | 2025 | Neffy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $90.18 | 2021 | |
| Karl Storz Endoscopy-America | $26.12 | 2023 | N.A. |
| Alcon Vision LLC | $24.89 | 2023 | Lensx |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.63 | 2019 | |
| Bausch & Lomb Americas INC. | $17.17 | 2022 | |
| Kaleo, INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sicard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.